Investing.com -- Axogen (NASDAQ:AXGN) stock declined 9% after the U.S. Food and Drug Administration (FDA) extended its review ...

S&P forecasts SK Hynix’s revenue will increase by about 24% in 2025 before moderating to approximately 6% growth in 2026. The ...

Investing.com -- Stifel raised its price target on Nvidia shares to $212 from $202 in a note on Monday, citing strong demand ...

For now, Trump’s gambit has left Nvidia shut out of the Chinese AI chip market and underscored the leverage China holds with ...

Investing.com -- Velo3D, Inc. (NASDAQ:VELO) stock surged 31% after the company announced its participation in a U.S.

The FDA pushed back the Prescription Drug User Fee Act (PDUFA) goal date by three months to December 5, 2025. The delay comes ...

Investing.com -- Valneva SE ADR (NASDAQ:VALN) stock tumbled 20.4% premarket Monday after the U.S. Food and Drug ...

Fitch noted that India’s economic outlook remains strong relative to peers, despite some moderation in momentum over the past ...

Investing.com -- Coya Therapeutics Inc (NASDAQ:COYA) stock surged 7.8% in premarket trading Monday after the company ...

Investing.com -- MannKind Corporation (NASDAQ:MNKD) shares dropped 2% on Monday after the company announced it will acquire ...

Investing.com -- AEye Inc (NASDAQ:LIDR) stock jumped 8.8% premarket Monday following the announcement of a strategic ...

PDS Biotech is currently advancing its VERSATILE-003 Phase 3 trial, building on these results. The company noted that durable ...